Danaher 3Q'25 Update
Following Sartorius 3Q’25 call, I mentioned in my update that I am actually a bit surprised that Danaher stock didn’t react more positively. Well, Danaher stock did pop ~8% after confirming bioprocessing’s continued growth and an initial 2026 guide that outlined HSD earnings growth even in a